Literature DB >> 16271394

Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry.

Fredrik Haeffner1, Danielle G Smith, Kevin J Barnham, Ashley I Bush.   

Abstract

The neurotoxicity of the amyloid-beta peptide (Abeta) is causally linked to Alzheimer's disease (AD) and may be related to the redox chemistry associated with its interactions with copper ions and cholesterol in brain tissue. We have used density functional theory (DFT) calculations to study the mechanism controlling the Abeta/Cu catalyzed oxidation reactions of cholesterol and ascorbate using a model system. The computed results based on a binuclear Cu complex predict that oxidation of cholesterol (yielding 4-cholesten-3-one as a specific product) proceeds at a slow rate when catalyzed by a Abeta/Cu(II)|His-|Cu(II)/Abeta) aggregate. The computed results also suggest that monomeric Abeta/Cu(II) is not able to oxidize cholesterol. DFT also predicted that Abeta will cross-link via covalent dityrosine formation during the oxidation of ascorbate but not during the oxidation of cholesterol. Experimental data were consistent with these predictions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16271394     DOI: 10.1016/j.jinorgbio.2005.09.011

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  13 in total

1.  Activation of T-lymphocytes by LDL-cholesterol.

Authors:  Borros Arneth
Journal:  Lipids       Date:  2008-12-17       Impact factor: 1.880

2.  Cholesterol potentiates beta-amyloid-induced toxicity in human neuroblastoma cells: involvement of oxidative stress.

Authors:  Patricia Ferrera; Octavio Mercado-Gómez; Martín Silva-Aguilar; Mahara Valverde; Clorinda Arias
Journal:  Neurochem Res       Date:  2008-02-21       Impact factor: 3.996

Review 3.  Therapeutics for Alzheimer's disease based on the metal hypothesis.

Authors:  Ashley I Bush; Rudolph E Tanzi
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

Review 4.  Copper in the brain and Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Robert Alan Cherny
Journal:  J Biol Inorg Chem       Date:  2009-10-28       Impact factor: 3.358

5.  Computational study of the binding of CuII to Alzheimer's amyloid-beta peptide: do Abeta42 and Abeta40 bind copper in identical fashion?

Authors:  Yogita Mantri; Marco Fioroni; Mu-Hyun Baik
Journal:  J Biol Inorg Chem       Date:  2008-07-08       Impact factor: 3.358

6.  The amyloid-beta peptide of Alzheimer's disease binds Cu(I) in a linear bis-his coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide.

Authors:  Jason Shearer; Veronika A Szalai
Journal:  J Am Chem Soc       Date:  2008-12-31       Impact factor: 15.419

7.  Characterization of oxidized guanosine 5'-triphosphate as a viable inhibitor of soluble guanylyl cyclase.

Authors:  Celeste Bolin; Fernando Cardozo-Pelaez
Journal:  Free Radic Biol Med       Date:  2009-01-10       Impact factor: 7.376

8.  Copper and its complexes in medicine: a biochemical approach.

Authors:  Isidoros Iakovidis; Ioannis Delimaris; Stylianos M Piperakis
Journal:  Mol Biol Int       Date:  2011-06-15

Review 9.  Metals and cholesterol: two sides of the same coin in Alzheimer's disease pathology.

Authors:  Bruce X Wong; Ya Hui Hung; Ashley I Bush; James A Duce
Journal:  Front Aging Neurosci       Date:  2014-05-15       Impact factor: 5.750

10.  Links between copper and cholesterol in Alzheimer's disease.

Authors:  Ya Hui Hung; Ashley I Bush; Sharon La Fontaine
Journal:  Front Physiol       Date:  2013-05-16       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.